Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOUNDS AS HEPATITIS C INHIBITORS AND USES THEREOF IN MEDICINE
Document Type and Number:
WIPO Patent Application WO/2016/127859
Kind Code:
A1
Abstract:
Provided herein are compounds as hepatitis C inhibitors and uses thereof in medicine. Specifically, provided herein is a compound of Formula (I) or a stereoisomer, a tautomer, an enantiomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or hepatitis C diseases. Also provided herein are a pharmaceutically acceptable composition containing such compound and a method of treating HCV infection or hepatitis C diseases comprising administering the compound or pharmaceutical composition thereof disclosed herein.

Inventors:
ZHANG YINGJUN (CN)
LUO HUICHAO (CN)
REN QINGYUN (CN)
XIONG ZHIMIN (CN)
LIU YANG (CN)
LEI YIBO (CN)
XIONG JINFENG (CN)
ZHANG JIANCUN (CN)
Application Number:
PCT/CN2016/073156
Publication Date:
August 18, 2016
Filing Date:
February 02, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SUNSHINE LAKE PHARMA CO LTD (CN)
International Classes:
C07D519/00; A61K31/395; A61P1/16; A61P31/14
Domestic Patent References:
WO2010088394A12010-08-05
Other References:
KAZMIERSKI, W. M. ET AL.: "Discovery of Novel Urea-Based Hepatitis C Protease Inhibitors with High Potency against Protease-Inhibitor-Resistant Mutants", J. MED. CHEM., vol. 55, no. 7, 3 April 2012 (2012-04-03)
Attorney, Agent or Firm:
TSINGYIHUA INTELLECTUAL PROPERTY LLC (Trade Building Zhaolanyuan,Tsinghua University, Qinghuayuan, Haidian District, Beijing 4, CN)
Download PDF: